Objective: The muscular axillary arch is a musculotendinous structure that arises from the latissimus dorsi muscle and crosses the axilla before inserting to the humerus, brachial fascia, or coracoid process. Case reports have described the neurovascular compression symptoms caused by this anatomic variant and have reported that the symptoms can be relieved by division of the muscle. However, there has been little information published regarding this topic in the neurosurgical literature.
Methods: We evaluated 70 axillary dissections in 35 cadavers to assess for the presence of this anomaly.
Results: The muscular axillary arch was identified unilaterally in 3 (8.6%) of the 35 cadavers. All 3 arches arose from the anterior border of the latissimus dorsi muscle and inserted at a point along a line extending from the coracoid process to the intertubercular groove deep to the insertion of the pectoralis major muscle. All 3 arches crossed over the neurovascular bundle in the axilla.
Conclusion: Compression by the muscular axillary arch should be considered in the differential diagnosis of patients with thoracic outlet and hyperabduction syndromes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1227/01.NEU.0000327033.22068.74 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An unusual variant of an accessory thoracic muscle.
Folia Morphol (Warsz)
January 2025
Department of Anatomy, School of Medicine, Faculty of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
Background: The anterior thoracic wall musculature presents significant morphological variability. The current literature describes a few accessory thoracic muscles (ATMs) and discusses possible clinical implications. The dissection report describes an unusual ATM variant.
View Article and Find Full Text PDFAngiographic Observation of the Perforators of Thoracodorsal Artery and Application of the Perforator Flaps in Repairing Adjacent Wounds.
J Craniofac Surg
December 2024
Department of Plastic Surgery, Nanjing Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, Jiangsu, China.
Objective: The thoracodorsal artery perforator flap has not been widely used in clinical practice partly due to a lack of imaging evidence. The authors aim to investigate the types of thoracic dorsal artery perforators through angiography and provide our experiences in the utilization of thoracic dorsal artery perforator flaps to repair adjacent wounds.
Methods: This study was divided into two parts.
Article Synopsis
- * This anatomical variation is significant due to its low occurrence and the need for surgeons to be aware of it during procedures involving the axillary region.
- * Lack of knowledge about the dorsalis major muscle arch can lead to complications during surgeries like axillary curage or breast reconstruction using a dorsalis major flap.
Sonographic localisation of lymph nodes suspicious of metastatic breast cancer to surgical axillary levels.
J Med Radiat Sci
November 2024
Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
The axillary lymph node (LN) burden of breast cancer patients guides multidisciplinary management and treatment regimes. Sonographic imaging is used to identify the presence, number and location of axillary LNs suspicious of malignancy and used to guide nodal fine needle aspirations and biopsies. Axillary LNs suspicious of harbouring breast cancer metastasis can be localised to three surgical axillary levels, numbered according to their location relative to the pectoralis minor muscle and lymph flow.
View Article and Find Full Text PDFSafety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up.
Brain Dev
November 2024
Department of Rehabilitation, NHO Mie National Hospital, Tsu, Japan.
Background: Duchenne muscular dystrophy (DMD) is a hereditary neuromuscular disorder characterized by severe, progressive muscle wasting. Viltolarsen, a formulation consisting of exon 53-skipping antisense oligonucleotides of the dystrophin gene, has been indicated for some patients with DMD. However, reports describing the efficacy and safety of viltolarsen treatment in patients with DMD, particularly those comparing patients receiving viltolarsen with age- and time-period-matched controls, are limited.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!